Opposing actions of (R,R)-isomers and (S,S)-isomers of formoterol on T-cell function.
Steinke
John W
JW
Baramki
Dawn
D
Borish
Larry
L
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D015703:Antigens, CD / Q000096:biosynthesis / Q000187:drug effects; D000943:Antigens, Differentiation / Q000096:biosynthesis / Q000187:drug effects; D001249:Asthma / Q000276:immunology; D060908:CTLA-4 Antigen; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis / Q000187:drug effects; D004983:Ethanolamines / Q000737:chemistry* / Q000494:pharmacology*; D053222:Fas Ligand Protein / Q000096:biosynthesis / Q000187:drug effects; D005434:Flow Cytometry; D000068759:Formoterol Fumarate; D006801:Humans; D008875:Middle Aged; D013237:Stereoisomerism; D013601:T-Lymphocytes / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D015703:Antigens, CD; D000943:Antigens, Differentiation; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; D016207:Cytokines; D004983:Ethanolamines; D053222:Fas Ligand Protein; D000068759:Formoterol Fumarate